SJS Investment Consulting’s Fulgent Genetics FLGT Stock Holding History

SJS Investment Consulting’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$308	Buy	+15	New	+$254	﹤0.01%	2391

Other funds holding FLGT

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

SJS Investment Consulting's FLGT Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 15 shares worth $308. The stake represents ﹤0.01% of the portfolio and ranks #2391 among its holdings.

29 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

SJS Investment Consulting held 15 shares of Fulgent Genetics worth $308 as of Q2 2026.
Fulgent Genetics was a new SJS Investment Consulting position in Q2 2026.
Fulgent Genetics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2391 holding.
29 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.